ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 121 filers reported holding ANI PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 3.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $58 | +7.4% | 1 | 0.0% | 0.00% | – |
| Q2 2023 | $54 | +35.0% | 1 | 0.0% | 0.00% | – |
| Q1 2023 | $40 | 0.0% | 1 | 0.0% | 0.00% | – |
| Q4 2022 | $40 | – | 1 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 1 | -99.8% | 0.00% | – |
| Q4 2019 | $25,000 | -26.5% | 401 | -13.9% | 0.00% | -100.0% |
| Q3 2019 | $34,000 | -24.4% | 466 | -14.3% | 0.00% | 0.0% |
| Q2 2019 | $45,000 | +18.4% | 544 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $38,000 | +52.0% | 544 | -0.2% | 0.00% | – |
| Q4 2018 | $25,000 | -21.9% | 545 | -3.9% | 0.00% | -100.0% |
| Q3 2018 | $32,000 | -22.0% | 567 | -7.4% | 0.00% | 0.0% |
| Q2 2018 | $41,000 | +20.6% | 612 | +6.1% | 0.00% | 0.0% |
| Q1 2018 | $34,000 | – | 577 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
| Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
| Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
| Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
| Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
| MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
| Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
| Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
| 1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
| Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |